Spånga, Sweden

Jakob Dogan



 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Jakob Dogan

Introduction

Jakob Dogan is an innovative inventor based in Spånga, Sweden. He is known for his significant contributions in the field of engineered polypeptides, making strides in biomedical applications that could enhance the treatment of diseases in mammals, including humans. With two patents to his name, Dogan exemplifies creativity and ingenuity in modern science.

Latest Patents

Jakob Dogan's most recent patents focus on compositions, methods, and uses related to engineered polypeptides that exhibit a strong binding affinity for albumin. This novel approach not only explores the binding characteristics of these polypeptides but also uncovers new methodologies and uses that leverage this binding in various biomedical contexts. The implications of his work hold promise for advancing treatments for various diseases, enhancing therapeutic efficacy in medical applications.

Career Highlights

Dogan currently works for Affibody AB, a company renowned for its innovations in the field of biopharmaceuticals. His work there has positioned him at the forefront of protein engineering, where he collaborates on groundbreaking projects. With his two patents, Jakob demonstrates a commitment to translating scientific knowledge into practical solutions.

Collaborations

Throughout his journey, Jakob has collaborated with esteemed colleagues such as Lars Abrahmsén and Andreas Jonsson. These partnerships not only bolster his projects but also showcase a team-oriented approach to innovation. Working closely with experts in the field, Dogan is able to expand the horizons of his research and bring about meaningful advancements in therapeutic strategies.

Conclusion

Jakob Dogan's contributions to the field of engineered polypeptides exemplify the power of innovation in medicine. With his patents highlighting crucial methodologies for disease treatment, Dogan remains an influential figure at Affibody AB. His collaborative efforts further demonstrate the importance of teamwork in advancing scientific discovery and enhancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…